| SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters PJ Halfmann, S Iida, K Iwatsuki-Horimoto, T Maemura, M Kiso, ... Nature 603 (7902), 687-692, 2022 | 523 | 2022 |
| STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters R Boudewijns, HJ Thibaut, SJF Kaptein, R Li, V Vergote, L Seldeslachts, ... Nature communications 11 (1), 5838, 2020 | 277 | 2020 |
| Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection K Rosenke, K Meade-White, M Letko, C Clancy, F Hansen, Y Liu, ... Emerging microbes & infections 9 (1), 2673-2684, 2020 | 203 | 2020 |
| Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA. 2 R Uraki, M Kiso, S Iida, M Imai, E Takashita, M Kuroda, PJ Halfmann, ... Nature 607 (7917), 119-127, 2022 | 200 | 2022 |
| Characterization of SARS-CoV-2 Omicron BA. 4 and BA. 5 isolates in rodents R Uraki, PJ Halfmann, S Iida, S Yamayoshi, Y Furusawa, M Kiso, M Ito, ... Nature 612 (7940), 540-545, 2022 | 73 | 2022 |
| Disruption of adaptive immunity enhances disease in SARS-CoV-2-infected Syrian hamsters RL Brocato, LM Principe, RK Kim, X Zeng, JA Williams, Y Liu, R Li, ... Journal of virology 94 (22), 10.1128/jvi. 01683-20, 2020 | 65 | 2020 |
| gga-miR-155 enhances type I interferon expression and suppresses infectious burse disease virus replication via targeting SOCS1 and TANK B Wang, M Fu, Y Liu, Y Wang, X Li, H Cao, SJ Zheng Frontiers in cellular and infection microbiology 8, 55, 2018 | 46 | 2018 |
| Characterization of SARS-CoV-2 Omicron BA. 2.75 clinical isolates R Uraki, S Iida, PJ Halfmann, S Yamayoshi, Y Hirata, K Iwatsuki-Horimoto, ... Nature Communications 14 (1), 1620, 2023 | 20 | 2023 |
| The association of ribosomal protein L18 (RPL18) with infectious bursal disease virus viral protein VP3 enhances viral replication B Wang, X Duan, M Fu, Y Liu, Y Wang, X Li, H Cao, SJ Zheng Virus research 245, 69-79, 2018 | 20 | 2018 |
| Protection of human ACE2 transgenic Syrian hamsters from SARS CoV-2 variants by human polyclonal IgG from hyper-immunized transchromosomic bovines T Gilliland, Y Liu, R Li, M Dunn, E Cottle, Y Terada, Z Ryckman, M Alcorn, ... BioRxiv, 2021.07. 26.453840, 2021 | 19 | 2021 |
| Hamsters expressing human angiotensin-converting enzyme 2 develop severe disease following exposure to SARS-CoV-2 JW Golden, R Li, CR Cline, X Zeng, EM Mucker, AJ Fuentes-Lao, KW Spik, ... MBio 13 (1), e02906-21, 2022 | 18 | 2022 |
| Negative Regulation of Hepatic Inflammation by the Soluble Resistance-Related Calcium-Binding Protein via Signal Transducer and Activator of Transcription 3 X Li, Y Liu, Y Wang, J Liu, X Li, H Cao, X Gao, SJ Zheng Frontiers in immunology 8, 709, 2017 | 14 | 2017 |
| Generation and characterization of an Il2rg knockout Syrian hamster model for XSCID and HAdV-C6 infection in immunocompromised patients R Li, B Ying, Y Liu, JF Spencer, J Miao, AE Tollefson, JD Brien, Y Wang, ... Disease models & mechanisms 13 (8), dmm044602, 2020 | 10 | 2020 |
| Transchromosomic bovine-derived anti-SARS-CoV-2 polyclonal human antibodies protects hACE2 transgenic hamsters against multiple variants T Gilliland, M Dunn, Y Liu, MDH Alcorn, Y Terada, S Vasilatos, J Lundy, ... Iscience 26 (10), 2023 | 1 | 2023 |
| Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infection MM Slough, R Li, AS Herbert, G Lasso, AI Kuehne, SR Monticelli, ... Nature communications 14 (1), 4454, 2023 | | 2023 |
| Correction of an S Opsin Base-pair Deletion in Hamsters Using CRISPR-Cas9 MM Giarmarco, AF Neitz, JA Kuchenbecker, Z Wang, Y Liu, R Li, J Neitz, ... Investigative Ophthalmology & Visual Science 64 (8), 761-761, 2023 | | 2023 |
| Longitudinal analyses using 18F-Fluorodeoxyglucose positron emission tomography with computed tomography as a measure of COVID-19 severity in the aged, young, and humanized … Y Cong, JH Lee, DL Perry, K Cooper, H Wang, S Dixit, DX Liu, ... Antiviral Research 214, 105605, 2023 | | 2023 |
